MedPath
TGA Approval

OBIZUR susoctocog alfa (bhk) 500U antihemophilic factor (recombinant), porcine sequence powder for injection vial with water for injection syringe (236475)

236475

OBIZUR susoctocog alfa (bhk) 500U antihemophilic factor (recombinant), porcine sequence powder for injection vial with water for injection syringe

Takeda Pharmaceuticals Australia Pty Ltd

April 29, 2016

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/a77244c7764d9814138795ffe70b336f.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/eb17a52aa61fe645d42fc1b4985bc326.pdf

Active Ingredients

susoctocog alfa

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OBIZUR susoctocog alfa (bhk) 500U antihemophilic factor (recombinant), porcine sequence powder for injection vial with water for injection syringe (236475) - TGA 批准文号 | MedPath